|
WO2011044187A1
(en)
|
2009-10-08 |
2011-04-14 |
Schering Corporation |
Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
|
|
EP2485920B1
(en)
|
2009-10-08 |
2016-04-27 |
Merck Sharp & Dohme Corp. |
Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use
|
|
EP2694521B1
(en)
|
2011-04-07 |
2015-11-25 |
Merck Sharp & Dohme Corp. |
Pyrrolidine-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use
|
|
EP2694489B1
(en)
|
2011-04-07 |
2017-09-06 |
Merck Sharp & Dohme Corp. |
C5-c6 oxacyclic-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use
|
|
KR20140054295A
(ko)
*
|
2011-08-22 |
2014-05-08 |
머크 샤프 앤드 돔 코포레이션 |
Bace 억제제로서의 2-스피로-치환된 이미노티아진 및 그의 모노- 및 디옥시드, 조성물 및 그의 용도
|
|
EA026004B1
(ru)
*
|
2012-05-24 |
2017-02-28 |
Ф. Хоффманн-Ля Рош Аг |
5-АМИНО[1,4]ТИАЗИНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ β-СЕКРЕТАЗЫ 1
|
|
US9556135B2
(en)
*
|
2012-10-12 |
2017-01-31 |
Amgen, Inc. |
Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use
|
|
US9447085B2
(en)
|
2012-12-14 |
2016-09-20 |
Merck Sharp & Dohme Corp. |
Iminothiadiazine dioxides containing a thioamide, amidine, or amide oxime group as BACE inhibitors, compositions, and their use
|
|
CN104870000A
(zh)
*
|
2012-12-20 |
2015-08-26 |
默沙东公司 |
作为bace抑制剂的c5,c6氧杂环稠合的亚胺基噻嗪二氧化物化合物,组合物及其用途
|
|
EP2934534B1
(en)
*
|
2012-12-21 |
2017-12-13 |
Merck Sharp & Dohme Corp. |
C5-spiro iminothiadiazine dioxides as bace inhibitors
|
|
US9309263B2
(en)
|
2013-01-29 |
2016-04-12 |
Amgen Inc. |
Fused multi-cyclic sulfone compounds as inhibitors of beta-secretase and methods of use thereof
|
|
MX366855B
(es)
|
2013-03-01 |
2019-07-26 |
Amgen Inc |
Compuestos perfluorados de 5,6-dihidro-4h-1,3-oxazin-2-amina como inhibidores de beta-secretasa y metodos de uso.
|
|
JP6374889B2
(ja)
|
2013-03-08 |
2018-08-15 |
アムジエン・インコーポレーテツド |
β−セクレターゼ阻害剤としての過フッ素化シクロプロピル縮合１，３−オキサジン−２−アミン化合物、及び使用方法
|
|
WO2014150344A1
(en)
*
|
2013-03-15 |
2014-09-25 |
Merck Sharp & Dohme Corp. |
C2-azaspiro iminothiazine dioxides as bace inhibitors
|
|
US9428476B2
(en)
|
2013-03-15 |
2016-08-30 |
Merck Sharp & Dohme Corp. |
S-imino-S-oxo-iminothiadiazine compounds as BACE inhibitors, compositions, and their use
|
|
WO2014150331A1
(en)
|
2013-03-15 |
2014-09-25 |
Merck Sharp & Dohme Corp. |
S-imino-s-oxo iminothiazine compounds as bace inhibitors, compositions, and their use
|
|
WO2015017407A1
(en)
|
2013-07-30 |
2015-02-05 |
Amgen Inc. |
Bridged bicyclic amino thiazine dioxide compounds as inhibitors of beta- secretase
|
|
EP3083575B1
(en)
*
|
2013-12-18 |
2021-11-03 |
Merck Sharp & Dohme Corp. |
C-6 spirocarbocyclic iminothiadiazine dioxides as bace inhibitors, compositions, and their use
|
|
US9745324B2
(en)
|
2013-12-18 |
2017-08-29 |
Merck Sharp & Dohme Corp. |
Iminothiadiazepane dioxide compounds as BACE inhibitors, compositions, and their use
|
|
EP2918171A1
(en)
*
|
2014-03-14 |
2015-09-16 |
University of Vienna |
Novel plant growth regulators and their use in modulating organ number
|
|
AP2016009493A0
(en)
|
2014-04-10 |
2016-10-31 |
Pfizer |
2-AMINO-6-METHYL-4,4a,5,6-TETRAHYDROPYRANO[3,4-d][1,3]THIAZIN-8a(8H)-YL-1,3-THIAZOL-4-YL AMIDES
|
|
EP3148996B1
(en)
|
2014-06-02 |
2021-05-05 |
Merck Sharp & Dohme Corp. |
C2-carbocyclic iminothiazine dioxides as bace inhibitors, compositions, and their use
|
|
EP3172206B1
(en)
*
|
2014-07-25 |
2019-01-30 |
F.Hoffmann-La Roche Ag |
Pyridyl-triazabicycles
|
|
WO2016040226A1
(en)
*
|
2014-09-12 |
2016-03-17 |
Merck Sharp & Dohme Corp. |
S-imino-s-oxo iminothiazine compounds as bace inhibitors, compositions, and their use
|
|
WO2016118404A1
(en)
|
2015-01-20 |
2016-07-28 |
Merck Sharp & Dohme Corp. |
Iminothiadiazine dioxides bearing an amine-linked substituent as bace inhibitors, compositions, and their use
|
|
EP3271355B1
(en)
*
|
2015-03-20 |
2020-07-29 |
H. Hoffnabb-La Roche Ag |
Bace1 inhibitors
|
|
AU2016250519A1
(en)
*
|
2015-04-21 |
2017-11-30 |
Allgenesis Biotherapeutics, Inc. |
Compounds and their use as BACE1 inhibitors
|
|
WO2017024180A1
(en)
|
2015-08-06 |
2017-02-09 |
Amgen Inc. |
Vinyl fluoride cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
|
|
AU2016325665A1
(en)
|
2015-09-24 |
2018-03-08 |
Pfizer Inc. |
N-[2-(2-amino-6,6-disubstituted-4, 4a, 5, 6-tetrahydropyrano [3,4-d][1,3] thiazin-8a (8h)-yl) -1, 3-thiazol-4-yl] amides
|
|
WO2017051303A1
(en)
|
2015-09-24 |
2017-03-30 |
Pfizer Inc. |
Tetrahydropyrano[3,4-d][1,3]oxazin derivatives and their use as bace inhibitors
|
|
WO2017070089A1
(en)
|
2015-10-19 |
2017-04-27 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
DK3377488T3
(da)
|
2015-11-19 |
2022-10-03 |
Incyte Corp |
Heterocykliske forbindelser som immunomodulatorer
|
|
WO2017095759A1
(en)
|
2015-12-04 |
2017-06-08 |
Merck Sharp & Dohme Corp. |
C5-c6-carbocyclic fused iminothiadiazine dioxides as bace inhibitors, compositions, and their use
|
|
MA44075A
(fr)
*
|
2015-12-17 |
2021-05-19 |
Incyte Corp |
Dérivés de n-phényl-pyridine-2-carboxamide et leur utilisation en tant que modulateurs des interactions protéine/protéine pd-1/pd-l1
|
|
MY199705A
(en)
|
2015-12-22 |
2023-11-20 |
Incyte Corp |
Heterocyclic compounds as immunomodulators
|
|
TW201808950A
(zh)
|
2016-05-06 |
2018-03-16 |
英塞特公司 |
作為免疫調節劑之雜環化合物
|
|
US20170342060A1
(en)
|
2016-05-26 |
2017-11-30 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
SG11201811414TA
(en)
|
2016-06-20 |
2019-01-30 |
Incyte Corp |
Heterocyclic compounds as immunomodulators
|
|
EP3484866B1
(en)
|
2016-07-14 |
2022-09-07 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
MA46045A
(fr)
|
2016-08-29 |
2021-04-28 |
Incyte Corp |
Composés hétérocycliques utilisés comme immunomodulateurs
|
|
AU2017378316B2
(en)
|
2016-12-15 |
2021-04-01 |
Amgen Inc. |
Cyclopropyl fused thiazine derivatives as beta-secretase inhibitors and methods of use
|
|
MX387729B
(es)
|
2016-12-15 |
2025-03-18 |
Amgen Inc |
Derivados de dióxido de 1,4-tiazina y dióxido 1,2,4-tiadiazina como inhibidores de beta-secretasa y métodos de uso.
|
|
US10889579B2
(en)
|
2016-12-15 |
2021-01-12 |
Amgen Inc. |
Thiazine derivatives as β-secretase inhibitors and methods of use
|
|
ES2910367T3
(es)
|
2016-12-15 |
2022-05-12 |
Amgen Inc |
Derivados de tiazina y oxazina bicíclicos como inhibidores de beta-secretasa y métodos de uso
|
|
AU2017376441B2
(en)
|
2016-12-15 |
2021-10-14 |
Amgen Inc. |
Oxazine derivatives as beta-secretase inhibitors and methods of use
|
|
KR102641030B1
(ko)
|
2016-12-22 |
2024-02-29 |
인사이트 코포레이션 |
Pd-l1 내재화 유도제로서의 테트라하이드로 이미다조[4,5-c]피리딘 유도체
|
|
WO2018119266A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Benzooxazole derivatives as immunomodulators
|
|
WO2018119221A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Pyridine derivatives as immunomodulators
|
|
US20180179202A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
WO2018119236A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Triazolo[1,5-a]pyridine derivatives as immunomodulators
|
|
US11247987B2
(en)
|
2017-10-06 |
2022-02-15 |
Forma Therapeutics, Inc. |
Inhibiting ubiquitin specific peptidase 30
|
|
JP2021506921A
(ja)
*
|
2017-12-21 |
2021-02-22 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
放射性標識化合物
|
|
CA3093802A1
(en)
|
2018-03-13 |
2019-09-19 |
Shire Human Genetic Therapies, Inc. |
Substituted imidazopyridines as inhibitors of plasma kallikrein and uses thereof
|
|
FI3774791T3
(fi)
|
2018-03-30 |
2023-03-21 |
Incyte Corp |
Heterosyklisiä yhdisteitä immunomodulaattoreina
|
|
MX2020011382A
(es)
|
2018-04-27 |
2020-11-24 |
Shionogi & Co |
Derivados de tetrahidropiranoxazina que tienen actividad inhibidora de beta-secretasa 1 (bace1) selectiva.
|
|
BR112020022936A2
(pt)
|
2018-05-11 |
2021-02-02 |
Incyte Corporation |
derivados de tetra-hidro-imidazo[4,5-c]piridina como imunomoduladores de pd-l1
|
|
ES2988920T3
(es)
|
2018-05-17 |
2024-11-22 |
Forma Therapeutics Inc |
Compuestos bicíclicos fusionados útiles como inhibidores de la peptidasa 30 específica de ubiquitina
|
|
CN108997328B
(zh)
*
|
2018-09-06 |
2021-06-08 |
广东东阳光药业有限公司 |
亚氨基噻二嗪二氧化物衍生物及其用途
|
|
MX2021002981A
(es)
|
2018-10-05 |
2021-05-14 |
Forma Therapeutics Inc |
Pirrolinas fusionadas que actuan como inhibidores de la proteasa 30 especifica de la ubiquitina (usp30).
|
|
US11753406B2
(en)
|
2019-08-09 |
2023-09-12 |
Incyte Corporation |
Salts of a PD-1/PD-L1 inhibitor
|
|
CN114258392A
(zh)
*
|
2019-08-21 |
2022-03-29 |
卡尔维斯塔制药有限公司 |
酶抑制剂
|
|
CN114667289B
(zh)
|
2019-09-18 |
2025-08-26 |
武田药品工业有限公司 |
杂芳基血浆激肽释放酶抑制剂
|
|
ES2987744T3
(es)
|
2019-09-18 |
2024-11-18 |
Takeda Pharmaceuticals Co |
Inhibidores de calicreína plasmática y usos de los mismos
|
|
MX2022003578A
(es)
|
2019-09-30 |
2022-05-30 |
Incyte Corp |
Compuestos de pirido[3,2-d]pirimidina como inmunomoduladores.
|
|
BR112022009031A2
(pt)
|
2019-11-11 |
2022-10-11 |
Incyte Corp |
Sais e formas cristalinas de um inibidor de pd-1/pd-l1
|
|
US11780836B2
(en)
|
2020-11-06 |
2023-10-10 |
Incyte Corporation |
Process of preparing a PD-1/PD-L1 inhibitor
|
|
MX2023005362A
(es)
|
2020-11-06 |
2023-06-22 |
Incyte Corp |
Proceso para hacer un inhibidor de proteina de muerte programada 1 (pd-1)/ligando de muerte programada 1 (pd-l1) y sales y formas cristalinas del mismo.
|
|
TW202233615A
(zh)
|
2020-11-06 |
2022-09-01 |
美商英塞特公司 |
Ｐｄ—１／ｐｄ—ｌ１抑制劑之結晶形式
|
|
TW202404984A
(zh)
|
2022-04-28 |
2024-02-01 |
日商第一三共股份有限公司 |
苯并三唑化合物
|